InStride helps employers in the healthcare sector (as well as other sectors) to upskill their employees with workforce education programmes, which it provides to them in partnership with high-quality global academic institutions.
Insurance company AXA UK has acquired healthcare services provider HBSUK. It shows how the group is pursuing a wider remit than traditionally expected of insurance companies.
Consolidation has been the primary way that PE-backed private health care groups have grown in Europe. A lot of the low hanging fruit has now been picked. But canny investors are adopting new models to open up new consolidation opportunities.
Listed Saudi hospital group Dallah Health is eyeing strategic expansion in Saudi Arabia as part of its dual aims of becoming the leading healthcare provider in the Kingdom and helping to position the country as a leading medical tourism destination. Its strategic expansion is part of its efforts to support the national Vision 2030.
Contrary to reports in the Spanish media suggesting it is less profitable, Spanish healthcare group Ribera Salud’s president Alberto de Rosa tells HBI profits at the group are up.
Medicharme, a medium sized French nursing home group owned by UK PE investor G Squared, has entered liquidation. The company became insolvent due to rising costs and low occupancy. The company's 43 facilities will continue to operate as normal for the time being. Takeover offers for the facilities will be examined by the courts on March 21.
Australia-based multinational hospital group Ramsay’s half year results have gained a positive response from shareholders. But the work is not yet done on the firm’s flagging European segment.
Rumours are circulating that San Donato, Italy’s largest for-profit hospital group, is about to IPO. HBI speaks to an Italian market expert to see how likely this is.
Embattled French nursing home group Orpea has announced it will pursue a reverse share split on all outstanding company shares. This means current shares which are valued at around €0.01 each will be exchanged for new shares valued at €10 each, at an exchange rate of 1,000-for-one.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.